Technetium-99m pertechnetate and reduced technetium intermediates (Tc-99m pertechnetate)

Technetium-99m pertechnetate is a diagnostic radiopharmaceutical used extensively in nuclear medicine for functional imaging. It is the primary chemical form of technetium-99m obtained from a molybdenum-99 generator and acts as a biological analog to the iodide ion, being transported into cells via the sodium-iodide symporter (NIS). Reduced technetium intermediates are chemical species formed when the pertechnetate ion (TcO4-) is reduced to lower oxidation states, such as Tc(IV) or Tc(V), typically using stannous chloride as a reducing agent. This reduction is a critical step in radiopharmaceutical preparation, as it allows the technetium atom to coordinate with various chelating ligands to create organ-specific imaging agents. These agents are used to diagnose conditions ranging from thyroid dysfunction and Meckel's diverticulum to bone metastases and myocardial ischemia. Because it is a diagnostic agent rather than a biological entity being modulated for therapy, it is classified as a radiopharmaceutical rather than a therapeutic target (NIH/NLM DailyMed; StatPearls).

Other names

Sodium pertechnetate Tc-99m99mTcO4-Technetium (99mTc) pertechnetateReduced technetium speciesTechnetium-99m

Technetium-99m pertechnetate mimics the iodide ion and is actively transported into cells by the sodium-iodide symporter (NIS), though it does not undergo organification. Reduced technetium intermediates are generated through the chemical reduction of pertechnetate (typically from Tc(VII) to Tc(IV) or Tc(V)) using agents like stannous chloride, which allows the technetium to form stable complexes with various chelating ligands for targeted organ imaging (StatPearls, 2023; PubChem CID 16212932).